bupropion has been researched along with nomifensine in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (45.71) | 18.7374 |
| 1990's | 7 (20.00) | 18.2507 |
| 2000's | 4 (11.43) | 29.6817 |
| 2010's | 8 (22.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boswell, GE; Cooper, BR; Kelley, JL; Musso, DL; Soroko, FE | 1 |
| Hoffman, BT; Katz, JL; Kopajtic, T; Newman, AH | 1 |
| Chang, G; Di, L; Huang, Y; Lin, Z; Liston, TE; Scott, DO; Troutman, MD; Umland, JP | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Subbaiah, MAM | 1 |
| Gelenberg, AJ | 1 |
| Rothman, RB | 1 |
| Griffiths, RR; Lamb, RJ | 1 |
| Bergman, J; Johnson, SE; Madras, BK; Spealman, RD | 1 |
| Kruk, ZL; Millar, J; Stamford, JA | 1 |
| Becker, RE; Blitzer, RD | 1 |
| Kuhr, WG; May, LJ; Wightman, RM | 1 |
| Ostrow, D | 1 |
| Hayes, PE; Kristoff, CA | 1 |
| Hudson, JI; Pope, HG | 2 |
| Barnes, JC; Costall, B; Domeney, AM; Naylor, RJ | 1 |
| Altar, CA; Marshall, JF | 1 |
| Cole, JO | 1 |
| Bo, P; Formigli, L; Manzo, L; Patrucco, M; Savoldi, F | 1 |
| Golden, RN; Potter, WZ; Rudorfer, MV | 1 |
| Hamilton, MJ; Peck, AW; Smith, PR | 1 |
| Cubeddu, LX; Hoffmann, IS; James, MK | 1 |
| McKearney, JW | 1 |
| Chiu, LM; Reyes, A; Sitges, M | 1 |
| Davidson, C; Stamford, JA | 1 |
| Cadet, JL; Ladenheim, B; Tella, SR | 1 |
| Dwoskin, LP; Miller, DK; Sumithran, SP | 1 |
| Moser, A; Qadri, F; Sarkar, R; Thümen, A | 1 |
| Sugimoto, Y; Yamada, J; Yamada, S | 1 |
| Calipari, ES; Ferris, MJ; Jones, SR; Mateo, Y; Melchior, JR; Roberts, DC | 1 |
| Buoli, M; Cahn, W; Serati, M | 1 |
6 review(s) available for bupropion and nomifensine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Triple Reuptake Inhibitors as Potential Therapeutics for Depression and Other Disorders: Design Paradigm and Developmental Challenges.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Drug Design; Humans; Selective Serotonin Reuptake Inhibitors | 2018 |
Adverse reactions to five new antidepressants.
Topics: Acute Kidney Injury; Amoxapine; Animals; Antidepressive Agents; Bupropion; Cardiovascular Diseases; Dopamine Antagonists; Humans; Male; Maprotiline; Nomifensine; Priapism; Propiophenones; Seizures; Trazodone | 1986 |
Antidepressant drug therapy for bulimia: current status.
Topics: Antidepressive Agents; Bupropion; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Feeding and Eating Disorders; Fenfluramine; Humans; Hyperphagia; Lithium; Lithium Carbonate; Methamphetamine; Monoamine Oxidase Inhibitors; Nomifensine; Phenytoin; Placebos; Propiophenones; Valproic Acid | 1986 |
Second-generation antidepressants.
Topics: Alprazolam; Amoxapine; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trials as Topic; Dopamine; Double-Blind Method; Humans; Maprotiline; Nomifensine; Norepinephrine; Propiophenones; Propylamines; Seizures; Serotonin; Trazodone; Zimeldine | 1984 |
Alternative pharmacological strategies for adult ADHD treatment: a systematic review.
Topics: Adrenergic alpha-Agonists; Adult; Amphetamines; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bupropion; Central Nervous System Stimulants; Desipramine; Dopamine Agents; Droxidopa; Drug Combinations; Duloxetine Hydrochloride; Guanfacine; Histamine Agents; Humans; Lisdexamfetamine Dimesylate; Lithium Compounds; Lobeline; Mecamylamine; Memantine; Modafinil; Morpholines; Nicotinic Agonists; Nicotinic Antagonists; Nomifensine; Paroxetine; Pyridines; Pyridoxine; Pyrrolidonecarboxylic Acid; Quinazolinones; Reboxetine; Venlafaxine Hydrochloride; Wakefulness-Promoting Agents | 2016 |
5 trial(s) available for bupropion and nomifensine
| Article | Year |
|---|---|
The new generation antidepressants: promising innovations or disappointments?
Topics: Alprazolam; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trials as Topic; Depressive Disorder; Dopamine; Drug Evaluation; Fluoxetine; Humans; Maprotiline; Nomifensine; Norepinephrine; Propiophenones; Propylamines; Receptors, Neurotransmitter; Serotonin; Trazodone; Zimeldine | 1985 |
Antidepressant drug therapy for bulimia: current status.
Topics: Antidepressive Agents; Bupropion; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Feeding and Eating Disorders; Fenfluramine; Humans; Hyperphagia; Lithium; Lithium Carbonate; Methamphetamine; Monoamine Oxidase Inhibitors; Nomifensine; Phenytoin; Placebos; Propiophenones; Valproic Acid | 1986 |
Where are those new antidepressants we were promised?
Topics: Antidepressive Agents; Bupropion; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Humans; Legislation, Drug; Mianserin; Nomifensine; Propiophenones; Selegiline; United States; United States Food and Drug Administration | 1988 |
Second-generation antidepressants.
Topics: Alprazolam; Amoxapine; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trials as Topic; Dopamine; Double-Blind Method; Humans; Maprotiline; Nomifensine; Norepinephrine; Propiophenones; Propylamines; Seizures; Serotonin; Trazodone; Zimeldine | 1984 |
Effects of bupropion, nomifensine and dexamphetamine on performance, subjective feelings, autonomic variables and electroencephalogram in healthy volunteers.
Topics: Adult; Antidepressive Agents; Blood Pressure; Bupropion; Clinical Trials as Topic; Dextroamphetamine; Double-Blind Method; Electroencephalography; Emotions; Female; Heart Rate; Humans; Isoquinolines; Male; Nomifensine; Propiophenones; Psychomotor Performance | 1983 |
26 other study(ies) available for bupropion and nomifensine
| Article | Year |
|---|---|
(2S,3S,5R)-2-(3,5-difluorophenyl)-3,5-dimethyl-2-morpholinol: a novel antidepressant agent and selective inhibitor of norepinephrine uptake.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Dose-Response Relationship, Drug; Mice; Morpholines; Norepinephrine; Rats | 1996 |
2D QSAR modeling and preliminary database searching for dopamine transporter inhibitors using genetic algorithm variable selection of Molconn Z descriptors.
Topics: Algorithms; Binding, Competitive; Carrier Proteins; Databases, Factual; Dopamine; Dopamine Plasma Membrane Transport Proteins; Ligands; Membrane Glycoproteins; Membrane Transport Proteins; Models, Molecular; Nerve Tissue Proteins; Quantitative Structure-Activity Relationship; Radioligand Assay; Reproducibility of Results; Software | 2000 |
Species independence in brain tissue binding using brain homogenates.
Topics: Animals; Brain; Dogs; Guinea Pigs; Humans; Macaca fascicularis; Mice; Rats; Species Specificity | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Imperfect drugs in an imperfect world.
Topics: Bulimia; Bupropion; Clinical Trials as Topic; Clozapine; Depressive Disorder; Humans; Nomifensine; Product Surveillance, Postmarketing; Schizophrenia | 1992 |
High affinity dopamine reuptake inhibitors as potential cocaine antagonists: a strategy for drug development.
Topics: Benztropine; Bupropion; Cocaine; Dopamine; Drug Evaluation, Preclinical; Humans; Mazindol; Nomifensine; Propiophenones; Substance-Related Disorders | 1990 |
Self-administration in baboons and the discriminative stimulus effects in rats of bupropion, nomifensine, diclofensine and imipramine.
Topics: Animals; Antidepressive Agents; Bupropion; Conditioning, Operant; Discrimination, Psychological; Imipramine; Isoquinolines; Male; Nomifensine; Papio; Propiophenones; Rats; Rats, Inbred Strains; Reinforcement Schedule; Self Administration; Substance-Related Disorders | 1990 |
Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys.
Topics: Animals; Bupropion; Cocaine; Dopamine; Male; Mazindol; Methylphenidate; Neurotransmitter Uptake Inhibitors; Nomifensine; Piperazines; Propiophenones; Saimiri; Self Administration | 1989 |
Dissociation of the actions of uptake blockers upon dopamine overflow and uptake in the rat nucleus accumbens: in vivo voltammetric data.
Topics: Animals; Benztropine; Bupropion; Cocaine; Dopamine; Electric Stimulation; Electrochemistry; Levodopa; Male; Microelectrodes; Neurotransmitter Uptake Inhibitors; Nomifensine; Nucleus Accumbens; Piperazines; Propiophenones; Rats; Rats, Inbred Strains; Septal Nuclei | 1989 |
Characterization of the bupropion cue in the rat: lack of evidence for a dopaminergic mechanism.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Brain; Bromocriptine; Bupropion; Central Nervous System Stimulants; Cues; Generalization, Stimulus; Levodopa; Male; Nomifensine; Propiophenones; Rats; Receptors, Dopamine; Viloxazine | 1985 |
Differentiation of dopamine overflow and uptake processes in the extracellular fluid of the rat caudate nucleus with fast-scan in vivo voltammetry.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Benztropine; Bupropion; Caudate Nucleus; Dopamine; Electric Stimulation; Electrochemistry; Extracellular Space; Kinetics; Levodopa; Male; Microelectrodes; Neurotransmitter Uptake Inhibitors; Nomifensine; Piperazines; Propiophenones; Rats; Rats, Inbred Strains | 1988 |
Lithium and bupropion antagonise the phasic changes in locomotor activity caused by dopamine infused into the rat nucleus accumbens.
Topics: Amitriptyline; Animals; Antidepressive Agents; Bupropion; Dopamine Antagonists; Female; Imipramine; Lithium; Motor Activity; Nomifensine; Nucleus Accumbens; Propiophenones; Rats; Rats, Inbred Strains; Septal Nuclei | 1986 |
Striatal dopamine uptake and swim performance of the aged rat.
Topics: Aging; Animals; Bupropion; Corpus Striatum; Desipramine; Dopamine; Dopamine Antagonists; Male; Motor Activity; Nomifensine; Olfactory Bulb; Propiophenones; Rats; Rats, Inbred F344; Swimming | 1986 |
Newer antidepressants in the treatment of bulimia nervosa.
Topics: Antidepressive Agents; Bulimia; Bupropion; Humans; Lithium; Lithium Carbonate; Nomifensine; Propiophenones; Trazodone | 1987 |
Behavioral and eegraphic changes induced by dopaminergic antidepressants in rabbits.
Topics: Animals; Antidepressive Agents; Autonomic Nervous System; Behavior, Animal; Body Temperature; Bupropion; Dibenzocycloheptenes; Electroencephalography; Heart Rate; Nomifensine; Propiophenones; Pupil; Rabbits; Receptors, Dopamine; Respiration; Time Factors | 1985 |
Frequency-dependent effects of neuronal uptake inhibitors on the autoreceptor-mediated modulation of dopamine and acetylcholine release from the rabbit striatum.
Topics: Acetylcholine; Animals; Apomorphine; Benztropine; Bupropion; Cocaine; Corpus Striatum; Dopamine; Dopamine Antagonists; Drug Interactions; Electric Stimulation; Neurons; Nomifensine; Propiophenones; Rabbits; Sulpiride | 1983 |
Effects of dopamine uptake inhibitors on schedule-controlled behavior in the squirrel monkey.
Topics: Animals; Behavior, Animal; Benztropine; Bupropion; Conditioning, Operant; Dopamine; Electroshock; Male; Mazindol; Nomifensine; Propiophenones; Psychotropic Drugs; Reinforcement Schedule; Saimiri | 1982 |
Dopamine transporter mediated release of dopamine: role of chloride.
Topics: Action Potentials; Animals; Bupropion; Calcium; Carrier Proteins; Chlorides; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Nomifensine; Perfusion; Rats; Rats, Wistar; Secretory Rate; Synaptosomes | 1994 |
Simultaneous real-time correlation of drug effects on dopamine efflux and uptake in rat striatal slices.
Topics: Animals; Biological Transport; Bupropion; Caudate Nucleus; Corpus Striatum; Dopamine; Dopamine Antagonists; In Vitro Techniques; Kinetics; Male; Nalidixic Acid; Naphthyridines; Nomifensine; Nucleus Accumbens; Piperazines; Putamen; Rats; Rats, Wistar; Time Factors | 1993 |
Differential regulation of dopamine transporter after chronic self-administration of bupropion and nomifensine.
Topics: Animals; Bupropion; Carrier Proteins; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Nomifensine; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Self Administration | 1997 |
Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.
Topics: Animals; Bupropion; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Electric Stimulation; Hippocampus; In Vitro Techniques; Kinetics; Male; Mecamylamine; Membrane Glycoproteins; Membrane Transport Proteins; Neostriatum; Nerve Tissue Proteins; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nomifensine; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Symporters | 2002 |
GBR-12909 effect on dopamine outflow depends on phosphorylation in the caudate nucleus of the rat.
Topics: Animals; Bupropion; Caudate Nucleus; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Enzyme Activators; Enzyme Inhibitors; Female; Nomifensine; Okadaic Acid; Organ Culture Techniques; Phosphoprotein Phosphatases; Phosphorylation; Piperazines; Protein Kinase C; Rats; Rats, Wistar; Sodium Channel Blockers | 2002 |
Involvement of dopamine receptors in the anti-immobility effects of dopamine re-uptake inhibitors in the forced swimming test.
Topics: Animals; Benzazepines; Bupropion; Depression; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Male; Mice; Motor Activity; Nomifensine; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride; Swimming | 2004 |
Cocaine self-administration produces pharmacodynamic tolerance: differential effects on the potency of dopamine transporter blockers, releasers, and methylphenidate.
Topics: Animals; Bupropion; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Tolerance; Male; Methylphenidate; Nomifensine; Rats; Rats, Sprague-Dawley; Self Administration | 2012 |